{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["diabetes complications", "diabetes mellitus", "glucagon-like peptide-1 receptor agonist", "newer drugs", "phytochemicals"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38931402", "DateRevised": {"Year": "2024", "Month": "06", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["736", "10.3390/ph17060736"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "05"}], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "17", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "05"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus.", "Abstract": {"AbstractText": ["Currently, there is no known cure for diabetes. Different pharmaceutical therapies have been approved for the management of type 2 diabetes mellitus (T2DM), some are in clinical trials and they have been classified according to their route or mechanism of action. Insulin types, sulfonylureas, biguanides, alpha-glucosidase inhibitors, thiazolidinediones, meglitinides, sodium-glucose cotransporter type 2 inhibitors, and incretin-dependent therapies (glucagon-like peptide-1 receptor agonists: GLP-1R, and dipeptidyl peptidase 4 inhibitors: DPP-4). Although some of the currently available drugs are effective in the management of T2DM, the side effects resulting from prolonged use of these drugs remain a serious challenge. GLP-1R agonists are currently the preferred medications to include when oral metformin alone is insufficient to manage T2DM. Medicinal plants now play prominent roles in the management of various diseases globally because they are readily available and affordable as well as having limited and transient side effects. Recently, studies have reported the ability of phytochemicals to activate glucagon-like peptide-1 receptor (GLP-1R), acting as an agonist just like the GLP-1R agonist with beneficial effects in the management of T2DM. Consequently, we propose that careful exploration of phytochemicals for the development of novel therapeutic candidates as GLP-1R agonists will be a welcome breakthrough in the management of T2DM and the co-morbidities associated with T2DM."]}, "AuthorList": [{"Identifier": ["0000-0003-3697-5769"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "Center for Genomics Research and Innovation, National Biotechnology Development Agency, Abuja 09004, Nigeria."}, {"Identifier": [], "Affiliation": "Institute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}], "LastName": "Abiola", "ForeName": "Julianah Ore", "Initials": "JO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}], "LastName": "Oluyemi", "ForeName": "Ayoola Abidemi", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Industrial Chemistry Unit, Department of Chemical Sciences, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}], "LastName": "Idowu", "ForeName": "Olajumoke Tolulope", "Initials": "OT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Mathematics, Science and Technology Education, Faculty of Education, University of Zululand, Kwadlangezwa 3886, South Africa."}], "LastName": "Oyinloye", "ForeName": "Oluwatoyin Mary", "Initials": "OM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, PA 19121, USA."}], "LastName": "Ubah", "ForeName": "Chukwudi Sunday", "Initials": "CS"}, {"Identifier": ["0000-0001-5445-4209"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biochemistry Unit, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}], "LastName": "Owolabi", "ForeName": "Olutunmise Victoria", "Initials": "OV"}, {"Identifier": ["0000-0002-7453-5097"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta 111101, Nigeria."}], "LastName": "Somade", "ForeName": "Oluwatobi T", "Initials": "OT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "College of Medicine, Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan."}], "LastName": "Onikanni", "ForeName": "Sunday Amos", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "Phytomedicine and Molecular Toxicology Research Laboratory, Department of Biochemistry, Federal University Oye-Ekiti, Oye-Ekiti 371104, Nigeria."}], "LastName": "Ajiboye", "ForeName": "Basiru Olaitan", "Initials": "BO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology and Structural Biology (BSB) Group, Department of Biochemistry and Microbiology, University of Zululand, Kwadlangezwa 3886, South Africa."}], "LastName": "Osunsanmi", "ForeName": "Foluso Oluwagbemiga", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Genomics Research and Innovation, National Biotechnology Development Agency, Abuja 09004, Nigeria."}], "LastName": "Nash", "ForeName": "Oyekanmi", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}], "LastName": "Omotuyi", "ForeName": "Olaposi Idowu", "Initials": "OI"}, {"Identifier": ["0000-0003-2165-7936"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytomedicine, Biochemical Toxicology and Biotechnology Research Laboratories, Department of Biochemistry, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "Institute of Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria."}, {"Identifier": [], "Affiliation": "Biotechnology and Structural Biology (BSB) Group, Department of Biochemistry and Microbiology, University of Zululand, Kwadlangezwa 3886, South Africa."}], "LastName": "Oyinloye", "ForeName": "Babatunji Emmanuel", "Initials": "BE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Karamanou M., Protogerou A., Tsoucalas G., Androutsos G., Poulakou-Rebelakou E. Milestones in the history of diabetes mellitus: The main contributors. World J. Diabetes. 2016;7:1. doi: 10.4239/wjd.v7.i1.1.", "ArticleIdList": ["10.4239/wjd.v7.i1.1", "PMC4707300", "26788261"]}, {"Citation": "Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Magliano D.J., Stein C., Basit A., Chan J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.", "ArticleIdList": ["10.1016/j.diabres.2021.109119", "PMC11057359", "34879977"]}, {"Citation": "Uloko A.E., Musa B.M., Ramalan M.A., Gezawa I.D., Puepet F.H., Uloko A.T., Borodo M.M., Sada K.B. Prevalence and risk factors for diabetes mellitus in Nigeria: A systematic review and meta-analysis. Diabetes Ther. 2018;9:1307\u20131316. doi: 10.1007/s13300-018-0441-1.", "ArticleIdList": ["10.1007/s13300-018-0441-1", "PMC5984944", "29761289"]}, {"Citation": "Solis-Herrera C., Triplitt C., Reasner C., DeFronzo R.A., Cersosimo E. Endotext [Internet] MDText.com, Inc.; South Dartmouth, MA, USA: 2018. Classification of Diabetes Mellitus."}, {"Citation": "Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018;14:88\u201398. doi: 10.1038/nrendo.2017.151.", "ArticleIdList": ["10.1038/nrendo.2017.151", "29219149"]}, {"Citation": "Naveen J., Baskaran V. Antidiabetic plant-derived nutraceuticals: A critical review. Eur. J. Nutr. 2018;57:1275\u20131299. doi: 10.1007/s00394-017-1552-6.", "ArticleIdList": ["10.1007/s00394-017-1552-6", "29022103"]}, {"Citation": "Pecoits-Filho R., Abensur H., Bet\u00f4nico C.C., Machado A.D., Parente E.B., Queiroz M., Salles J.E.N., Titan S., Vencio S. Interactions between kidney disease and diabetes: Dangerous liaisons. Diabetol. Metab. Syndr. 2016;8:50. doi: 10.1186/s13098-016-0159-z.", "ArticleIdList": ["10.1186/s13098-016-0159-z", "PMC4964290", "27471550"]}, {"Citation": "Gronda E., Jessup M., Iacoviello M., Palazzuoli A., Napoli C. Glucose metabolism in the kidney: Neurohormonal activation and heart failure development. J. Am. Heart Assoc. 2020;9:e018889. doi: 10.1161/JAHA.120.018889.", "ArticleIdList": ["10.1161/JAHA.120.018889", "PMC7763788", "33190567"]}, {"Citation": "Meyer C., Stumvoll M., Nadkarni V., Dostou J., Mitrakou A., Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J. Clin. Investig. 1998;102:619\u2013624. doi: 10.1172/JCI2415.", "ArticleIdList": ["10.1172/JCI2415", "PMC508922", "9691098"]}, {"Citation": "Eastman D.M., Dreyer M.A.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2022.  [(accessed on 10 January 2024)]. Neuropathic Ulcer. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK559214/", "ArticleIdList": ["32644640"]}, {"Citation": "Bondar A., Popa A.R., Papanas N., Popoviciu M., Vesa C.M., Sabau M., Daina C., Stoica R.A., Katsiki N., Stoian A.P. Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options. Exp. Ther. Med. 2021;22:690. doi: 10.3892/etm.2021.10122.", "ArticleIdList": ["10.3892/etm.2021.10122", "PMC8111877", "33986855"]}, {"Citation": "Watkins P.J. Progression of diabetic autonomic neuropathy. Diabet. Med. 1993;10:77S\u201378S. doi: 10.1111/j.1464-5491.1993.tb00206.x.", "ArticleIdList": ["10.1111/j.1464-5491.1993.tb00206.x", "8334849"]}, {"Citation": "Edmonds M., Manu C., Vas P. The current burden of diabetic foot disease. J. Clin. Orthop. Trauma. 2021;17:88\u201393. doi: 10.1016/j.jcot.2021.01.017.", "ArticleIdList": ["10.1016/j.jcot.2021.01.017", "PMC7919962", "33680841"]}, {"Citation": "Urso B., Ghias M., John A., Khachemoune A. Neuropathic ulcers: A focused review. Int. J. Dermatol. 2021;60:e383\u2013e389. doi: 10.1111/ijd.15362.", "ArticleIdList": ["10.1111/ijd.15362", "33332620"]}, {"Citation": "Einarson T.R., Acs A., Ludwig C., Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc. Diabetol. 2018;17:83. doi: 10.1186/s12933-018-0728-6.", "ArticleIdList": ["10.1186/s12933-018-0728-6", "PMC5994068", "29884191"]}, {"Citation": "Ma C.X., Ma X.N., Guan C.H., Li Y.D., Mauricio D., Fu S.B. Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management. Cardiovasc. Diabetol. 2022;21:74. doi: 10.1186/s12933-022-01516-6.", "ArticleIdList": ["10.1186/s12933-022-01516-6", "PMC9107726", "35568946"]}, {"Citation": "Sharma A., Mittal S., Aggarwal R., Chauhan M.K. Diabetes and cardiovascular disease: Inter-relation of risk factors and treatment. Future J. Pharm. Sci. 2020;6:130. doi: 10.1186/s43094-020-00151-w.", "ArticleIdList": ["10.1186/s43094-020-00151-w"]}, {"Citation": "Bjornsdottir H.H., Rawshani A., Rawshani A., Franz\u00e9n S., Svensson A.M., Sattar N., Gudbj\u00f6rnsdottir S. A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time. Sci. Rep. 2020;10:17376. doi: 10.1038/s41598-020-73668-y.", "ArticleIdList": ["10.1038/s41598-020-73668-y", "PMC7566479", "33060631"]}, {"Citation": "Ballotari P., Vicentini M., Manicardi V., Gallo M., Chiatamone Ranieri S., Greci M., Giorgi Rossi P. Diabetes and risk of cancer incidence: Results from a population-based cohort study in northern Italy. BMC Cancer. 2017;17:703. doi: 10.1186/s12885-017-3696-4.", "ArticleIdList": ["10.1186/s12885-017-3696-4", "PMC5657107", "29070034"]}, {"Citation": "Yee L.D., Mortimer J.E., Natarajan R., Dietze E.C., Seewaldt V.L. Metabolic health, insulin, and breast cancer: Why oncologists should care about insulin. Front. Endocrinol. 2020;11:58. doi: 10.3389/fendo.2020.00058.", "ArticleIdList": ["10.3389/fendo.2020.00058", "PMC7045050", "32153503"]}, {"Citation": "Haeusler R.A., McGraw T.E., Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat. Rev. Mol. Cell Biol. 2018;19:31\u201344. doi: 10.1038/nrm.2017.89.", "ArticleIdList": ["10.1038/nrm.2017.89", "PMC5894887", "28974775"]}, {"Citation": "Sun G., Kashyap S.R. Cancer risk in type 2 diabetes mellitus: Metabolic links and therapeutic complications. J. Nutr. Metab. 2011;2011:708183. doi: 10.1155/2011/708183.", "ArticleIdList": ["10.1155/2011/708183", "PMC3136221", "21773024"]}, {"Citation": "Jin F., Wu Z., Hu X., Zhang J., Gao Z., Han X., Qin J., Li C., Wang Y. The PI3K/Akt/GSK-3\u03b2/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility. Cancer Biol. Med. 2019;16:38.", "ArticleIdList": ["PMC6528454", "31119045"]}, {"Citation": "Mirzaei H., Hamblin M.R. Regulation of glycolysis by non-coding RNAs in cancer: Switching on the Warburg effect. Mol. Ther.-Oncolytics. 2020;19:218\u2013239. doi: 10.1016/j.omto.2020.10.003.", "ArticleIdList": ["10.1016/j.omto.2020.10.003", "PMC7666327", "33251334"]}, {"Citation": "Yu H., Zhong X., Gao P., Shi J., Wu Z., Guo Z., Wang Z., Song Y. The potential effect of metformin on cancer: An umbrella review. Front. Endocrinol. 2019;10:617. doi: 10.3389/fendo.2019.00617.", "ArticleIdList": ["10.3389/fendo.2019.00617", "PMC6760464", "31620081"]}, {"Citation": "Wu H., Huang D., Zhou H., Sima X., Wu Z., Sun Y., Wang L., Ruan Y., Wu Q., Wu F., et al. Metformin: A promising drug for human cancers. Oncol. Lett. 2022;24:204. doi: 10.3892/ol.2022.13325.", "ArticleIdList": ["10.3892/ol.2022.13325", "PMC9178677", "35720480"]}, {"Citation": "Zhang R., Cai X.L., Liu L., Han X.Y., Ji L.N. Type 1 diabetes induced by immune checkpoint inhibitors. Chin. Med. J. 2020;133:2595\u20132598. doi: 10.1097/CM9.0000000000000972.", "ArticleIdList": ["10.1097/CM9.0000000000000972", "PMC7722553", "32842016"]}, {"Citation": "Singh R., Bhat G.A., Sharma P. GLP-1 secretagogues potential of medicinal plants in management of diabetes. J. Pharmacogn. Phytochem. 2015;4:197\u2013202."}, {"Citation": "Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., Zinman B. Medical management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52:17\u201330. doi: 10.1007/s00125-008-1157-y.", "ArticleIdList": ["10.1007/s00125-008-1157-y", "18941734"]}, {"Citation": "Amori R.E., Lau J., Pittas A.G. Efficacy and safety of incretin therapy in type 2 diabetes: Systematic review and meta-analysis. JAMA. 2007;298:194\u2013206. doi: 10.1001/jama.298.2.194.", "ArticleIdList": ["10.1001/jama.298.2.194", "17622601"]}, {"Citation": "Phung O.J., Scholle J.M., Talwar M., Coleman C.I. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA. 2010;303:1410\u20131418. doi: 10.1001/jama.2010.405.", "ArticleIdList": ["10.1001/jama.2010.405", "20388897"]}, {"Citation": "Pratley R.E., Nauck M., Bailey T., Montanya E., Cuddihy R., Filetti S., Thomsen A.B., S\u00f8ndergaard R.E., Davies M. Liraglutide vs sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: A 26-week, randomised, parallelgroup, open-label trial. Lancet. 2010;375:1447\u20131456. doi: 10.1016/S0140-6736(10)60307-8.", "ArticleIdList": ["10.1016/S0140-6736(10)60307-8", "20417856"]}, {"Citation": "Flint A., Nazzal K., Jagielski P., Segel S., Zdravkovic M. Influence of hepatic impairment on pharmacokinetics of the long-acting human GLP-1 analogue liraglutide. Diabetes. 2007;56:A145.", "ArticleIdList": ["PMC2997321", "21175436"]}, {"Citation": "Jacobsen L.V., Hindsberger C., Robson R., Zdravkovic M. Pharmacokinetics of the long-acting human GLP-1 analogue liraglutide in subjects with renal impairment; Proceedings of the Program and Abstracts of the American Diabetes Association 67th Sessions; Chicago, IL, USA. 22\u201326 June 2007; p. 513."}, {"Citation": "Mannucci E., Ognibene A., Cremasco F., Bardini G., Mencucci A., Pierazzuoli E., Ciani S., Messeri G., Rotella C.M. Effect of Metformin on Glucagon-Like Peptide 1 (GLP-1) and Leptin Levels in Obese Nondiabetic Subjects. Diabetes Care. 2001;24:489\u2013494. doi: 10.2337/diacare.24.3.489.", "ArticleIdList": ["10.2337/diacare.24.3.489", "11289473"]}, {"Citation": "Maida A., Lamont B.J., Cao X., Drucker D.J. Metformin regulates the incretin receptor axis via a peroxisome proliferatoractivated receptor alpha-dependent pathway in mice. Diabetologia. 2011;54:339\u2013349. doi: 10.1007/s00125-010-1937-z.", "ArticleIdList": ["10.1007/s00125-010-1937-z", "20972533"]}, {"Citation": "Yao X., Chen L., McIntyre M.S., Danger D.P., Nystrom C.C., Smith C.D., Young A.A. Biguanide antidiabetic agents increase fecal bile acids via inhibition of apical sodium dependent bile acid transporter. Diabetes. 2010;59:611.", "ArticleIdList": ["0"]}, {"Citation": "Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10:167\u2013177. doi: 10.1016/j.cmet.2009.08.001.", "ArticleIdList": ["10.1016/j.cmet.2009.08.001", "PMC2739652", "19723493"]}, {"Citation": "Lenhard J.M., Croom D.K., Minnick D.T. Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments. Biochem. Biophys. Res. Commun. 2004;324:92\u201397. doi: 10.1016/j.bbrc.2004.09.021.", "ArticleIdList": ["10.1016/j.bbrc.2004.09.021", "15464987"]}, {"Citation": "Lindsay J.R., Duffy N.A., McKillop A.M., Ardill J., O\u2019Harte F.P.M., Flatt P.R., Bell P.M. Inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes. Diabet. Med. 2005;22:654\u2013657. doi: 10.1111/j.1464-5491.2005.01461.x.", "ArticleIdList": ["10.1111/j.1464-5491.2005.01461.x", "15842525"]}, {"Citation": "Kieffer T.J., Habener J.F. The Glucagon-Like Peptides. Endocr. Rev. 1999;20:876\u2013913. doi: 10.1210/edrv.20.6.0385.", "ArticleIdList": ["10.1210/edrv.20.6.0385", "10605628"]}, {"Citation": "Barnett A. Exenatide. Expert Opin. Pharmacother. 2007;8:2593\u20132608. doi: 10.1517/14656566.8.15.2593.", "ArticleIdList": ["10.1517/14656566.8.15.2593", "17931093"]}, {"Citation": "Nielsen L.L., Young A.A., Parkes D.G. Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improved glycemic control of type 2 diabetes. Regul. Pept. 2004;117:77\u201388. doi: 10.1016/j.regpep.2003.10.028.", "ArticleIdList": ["10.1016/j.regpep.2003.10.028", "14700743"]}, {"Citation": "Anderson S.L., Trujillo J.M. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann. Pharmacother. 2010;44:904\u2013909. doi: 10.1345/aph.1M676.", "ArticleIdList": ["10.1345/aph.1M676", "20371755"]}, {"Citation": "Smith N.K., Hackett T.A., Galli A., Flynn C.R. GLP-1, Molecular mechanisms and outcomes of a complex signaling system. Neurochem. Int. 2019;128:94\u2013105. doi: 10.1016/j.neuint.2019.04.010.", "ArticleIdList": ["10.1016/j.neuint.2019.04.010", "PMC7081944", "31002893"]}, {"Citation": "Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA. 1987;84:3434\u20133438. doi: 10.1073/pnas.84.10.3434.", "ArticleIdList": ["10.1073/pnas.84.10.3434", "PMC304885", "3033647"]}, {"Citation": "Baggio L.L., Drucker D.J. Biology of Incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131\u20132157. doi: 10.1053/j.gastro.2007.03.054.", "ArticleIdList": ["10.1053/j.gastro.2007.03.054", "17498508"]}, {"Citation": "Cho Y.M., Fujita Y., Kieffer T.J. Glucagon-like peptide-1, glucose homeostasis and beyond. Annu. Rev. Physiol. 2014;76:535\u2013559. doi: 10.1146/annurev-physiol-021113-170315.", "ArticleIdList": ["10.1146/annurev-physiol-021113-170315", "24245943"]}, {"Citation": "Holst J.J. The physiology of glucagon-like peptide 1. Physiol. Rev. 2007;87:1409\u20131439. doi: 10.1152/physrev.00034.2006.", "ArticleIdList": ["10.1152/physrev.00034.2006", "17928588"]}, {"Citation": "MacDonald P.E., El-kholy W., Riedel M.J., Salapatek A.M.F., Light P.E., Wheeler M.B. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes. 2002;51:S434\u2013S442. doi: 10.2337/diabetes.51.2007.S434.", "ArticleIdList": ["10.2337/diabetes.51.2007.S434", "12475787"]}, {"Citation": "Seino S., Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol. Rev. 2005;85:1303\u20131342. doi: 10.1152/physrev.00001.2005.", "ArticleIdList": ["10.1152/physrev.00001.2005", "16183914"]}, {"Citation": "Kang G., Chepurny O.G., Malester B., Rindler M.J., Rehmann H., Bos J.L., Schwede F., Coetzee W.A., Holz G.G. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic \u03b2 cells and rat INS-1 cells. J. Physiol. 2006;573:595\u2013609. doi: 10.1113/jphysiol.2006.107391.", "ArticleIdList": ["10.1113/jphysiol.2006.107391", "PMC1779745", "16613879"]}, {"Citation": "Light P.E., Manning Fox J.E., Riedel M.J., Wheeler M.B. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A-and ADP-dependent mechanism. Mol. Endocrinol. 2002;16:2135\u20132144. doi: 10.1210/me.2002-0084.", "ArticleIdList": ["10.1210/me.2002-0084", "12198249"]}, {"Citation": "Nakazaki M., Crane A., Hu M., Seghers V., Ullrich S., Aguilar-Bryan L., Bryan J. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets. Diabetes. 2002;51:3440\u20133449. doi: 10.2337/diabetes.51.12.3440.", "ArticleIdList": ["10.2337/diabetes.51.12.3440", "12453898"]}, {"Citation": "Shiota C., Larsson O., Shelton K.D., Shiota M., Efanov A.M., H\u00f8y M., Lindner J., Kooptiwut S., Juntti-Berggren L., Gromada J. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J. Biol. Chem. 2002;277:37176\u201337183. doi: 10.1074/jbc.M206757200.", "ArticleIdList": ["10.1074/jbc.M206757200", "12149271"]}, {"Citation": "Britsch S., Krippeitdrews P., Lang F., Gregor M., Drews G. Glucagon-like peptide-1 modulates Ca2+ current but not K+ ATP current in intact mouse pancreatic B-cells. Biochem. Biophys. Res. Commun. 1995;207:33\u201339. doi: 10.1006/bbrc.1995.1149.", "ArticleIdList": ["10.1006/bbrc.1995.1149", "7857285"]}, {"Citation": "Yada T., Itoh K., Nakata M. Glucagon-like peptide-1-(7\u201336) amide and a rise in cyclic adenosine 3\u2032, 5\u2032-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity. Endocrinology. 1993;133:1685\u20131692. doi: 10.1210/endo.133.4.8404610.", "ArticleIdList": ["10.1210/endo.133.4.8404610", "8404610"]}, {"Citation": "Leech C.A., Habener J.F. Insulinotropic glucagon-like peptide-1-mediated activation of non-selective cation currents in insulinoma cells is mimicked by maitotoxin. J. Biol. Chem. 1997;272:17987\u201317993. doi: 10.1074/jbc.272.29.17987.", "ArticleIdList": ["10.1074/jbc.272.29.17987", "9218425"]}, {"Citation": "Holz G.G., Leech C.A., Habener J.F. Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic \u03b2-Cells by the Insulinotropic Hormone Glucagon-like Peptide-1. J. Biol. Chem. 1995;270:17749\u201317757. doi: 10.1074/jbc.270.30.17749.", "ArticleIdList": ["10.1074/jbc.270.30.17749", "PMC3505614", "7543091"]}, {"Citation": "Holz IV IV G.G., Kiihtreiber W.M., Habener J.F. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7\u201337) Nature. 1993;361:362. doi: 10.1038/361362a0.", "ArticleIdList": ["10.1038/361362a0", "PMC2916679", "8381211"]}, {"Citation": "Beak S.A., Heath M.M., Small C.J., Morgan D.G.A., Ghatei M.A., Taylor A.D., Buckingham J.C., Bloom S.R., Smith D.M. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J. Clin. Investig. 1998;101:1334. doi: 10.1172/JCI610.", "ArticleIdList": ["10.1172/JCI610", "PMC508688", "9502775"]}, {"Citation": "Hayes M.R., Leichner T.M., Zhao S., Lee G.S., Chowansky A., Zimmer D., De Jonghe B.C., Kanoski S.E., Grill H.J., Bence K.K. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab. 2011;13:320\u2013330. doi: 10.1016/j.cmet.2011.02.001.", "ArticleIdList": ["10.1016/j.cmet.2011.02.001", "PMC3108145", "21356521"]}, {"Citation": "Gilman C.P., Perry T., Furukawa K., Grieg N.H., Egan J.M., Mattson M.P. Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons. J. Neurochem. 2003;87:1137\u20131144. doi: 10.1046/j.1471-4159.2003.02073.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.02073.x", "14622093"]}, {"Citation": "Collins L., Costello R.A.  StartPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2023.  [(accessed on 10 January 2024)]. Glucagon-like peptide-1 receptor agonists. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK551568/", "ArticleIdList": ["31855395"]}, {"Citation": "Hunt B., Malkin S.J.P., Moes R.G.J., Huisman E.L., Vandebrouck T., Wolffenbuttel B.H.R. Once-weekly semaglutide for patients with type 2 diabetes: A cost-effectiveness analysis in the Netherlands. BMJ Open Diabetes Res. Care. 2019;7:e000705. doi: 10.1136/bmjdrc-2019-000705.", "ArticleIdList": ["10.1136/bmjdrc-2019-000705", "PMC6777406", "31641522"]}, {"Citation": "Burcelin R., Gourdy P. Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity. Obes Rev. 2017;18:86\u201398. doi: 10.1111/obr.12465.", "ArticleIdList": ["10.1111/obr.12465", "27636208"]}, {"Citation": "Gourgari E., Wilhelm E.E., Hassanzadeh H., Aroda V.R., Shoulson I. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. J. Diabetes Complicat. 2017;31:1719\u20131727. doi: 10.1016/j.jdiacomp.2017.08.005.", "ArticleIdList": ["10.1016/j.jdiacomp.2017.08.005", "28939018"]}, {"Citation": "Janzen K.M., Steuber T.D., Nisly S.A. GLP-1 Agonists in Type 1 Diabetes Mellitus. Ann. Pharmacother. 2016;50:656\u2013665. doi: 10.1177/1060028016651279.", "ArticleIdList": ["10.1177/1060028016651279", "27252246"]}, {"Citation": "Sanford M. Dulaglutide: First global approval. Drugs. 2014;74:2097\u20132103. doi: 10.1007/s40265-014-0320-7.", "ArticleIdList": ["10.1007/s40265-014-0320-7", "25367716"]}, {"Citation": "Hinnen D. Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes. Diabetes Spectr. 2017;30:202\u2013210. doi: 10.2337/ds16-0026.", "ArticleIdList": ["10.2337/ds16-0026", "PMC5556578", "28848315"]}, {"Citation": "Madsbad S. Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists. Diabetes Obes. Metab. 2016;18:317\u2013332. doi: 10.1111/dom.12596.", "ArticleIdList": ["10.1111/dom.12596", "PMC5064617", "26511102"]}, {"Citation": "Ku H.C., Chen W.P., Su M.J. DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes. PLoS ONE. 2013;8:e54518. doi: 10.1371/journal.pone.0054518.", "ArticleIdList": ["10.1371/journal.pone.0054518", "PMC3554719", "23359639"]}, {"Citation": "Barale C., Buracco S., Cavalot F., Frascaroli C., Guerrasio A., Russo I. Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation. Thromb. Haemost. 2017;117:1115\u20131128. doi: 10.1160/TH16-07-0586.", "ArticleIdList": ["10.1160/TH16-07-0586", "PMC6291961", "28405672"]}, {"Citation": "Tang S.T., Tang H.Q., Su H., Wang Y., Zhou Q., Zhang Q., Wang Y., Zhu H. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation. Biomed. Pharmacother. 2019;113:108667. doi: 10.1016/j.biopha.2019.108667.", "ArticleIdList": ["10.1016/j.biopha.2019.108667", "30852419"]}, {"Citation": "Rakipovski G., Rolin B., N\u00f8hr J., Klewe I., Frederiksen K.S., Augustin R., Hecksher-S\u00f8rensen J., Ingvorsen C., Polex-Wolf J., Knudsen L.B. The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE\u2212/\u2212 and LDLr\u2212/\u2212 mice by a mechanism that includes inflammatory pathways. JACC Basic Transl. Sci. 2018;3:844\u2013857. doi: 10.1016/j.jacbts.2018.09.004.", "ArticleIdList": ["10.1016/j.jacbts.2018.09.004", "PMC6314963", "30623143"]}, {"Citation": "Secher A., Jelsing J., Baquero A.F., Hecksher-S\u00f8rensen J., Cowley M.A., Dalb\u00f8ge L.S., Hansen G., Grove K.L., Pyke C., Raun K., et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J. Clin. Investig. 2014;124:4473\u20134488. doi: 10.1172/JCI75276.", "ArticleIdList": ["10.1172/JCI75276", "PMC4215190", "25202980"]}, {"Citation": "Kadouh H., Chedid V., Halawi H., Burton D.D., Clark M.M., Khemani D., Vella A., Acosta A., Camilleri M. GLP-1 analog modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity. J. Clin. Endocrinol. Metab. 2020;105:1552\u20131563. doi: 10.1210/clinem/dgz140.", "ArticleIdList": ["10.1210/clinem/dgz140", "PMC7105351", "31665455"]}, {"Citation": "Schl\u00f6gl H., Kabisch S., Horstmann A., Lohmann G., M\u00fcller K., Lepsien J., Busse-Voigt F., Kratzsch J., Pleger B., Villringer A., et al. Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care. 2013;36:1933\u20131940. doi: 10.2337/dc12-1925.", "ArticleIdList": ["10.2337/dc12-1925", "PMC3687323", "23462665"]}, {"Citation": "Haj-Zaroubi M., Mattar N., Awabdeh S., Sweidan R., Markovics A., Klein J.D., Azaizeh H. Willow (Salix acmophylla Boiss.) Leaf and Branch Extracts Inhibit In Vitro Sporulation of Coccidia (Eimeria spp.) from Goats. Agriculture. 2024;14:648. doi: 10.3390/agriculture14050648.", "ArticleIdList": ["10.3390/agriculture14050648"]}, {"Citation": "Carmona F., Pereira AM S. Herbal medicines: Old and new concepts, truths and misunderstandings. Rev. Bras. Farmacogn. 2013;23:379\u2013385. doi: 10.1590/S0102-695X2013005000018.", "ArticleIdList": ["10.1590/S0102-695X2013005000018"]}, {"Citation": "Rabizadeh F., Mirian M.S., Doosti R., Kiani-Anbouhi R., Eftekhari E. Phytochemical Classification of Medicinal Plants Used in the Treatment of Kidney Disease Based on Traditional Persian Medicine. Evid.-Based Complement. Altern. Med. 2022;2022:8022599. doi: 10.1155/2022/8022599.", "ArticleIdList": ["10.1155/2022/8022599", "PMC9357710", "35958915"]}, {"Citation": "Ahmed M.N. Medicinal plant-based functional foods for the management of neurological health. Preprints. 2020:2020060311. doi: 10.20944/preprints202006.0311.v1.", "ArticleIdList": ["10.20944/preprints202006.0311.v1"]}, {"Citation": "AlAli M., Alqubaisy M., Aljaafari M.N., AlAli A.O., Baqais L., Molouki A., Abushelaibi A., Lai K.S., Lim S.H.E. Nutraceuticals: Transformation of conventional foods into health promoters/disease preventers and safety considerations. Molecules. 2021;26:2540. doi: 10.3390/molecules26092540.", "ArticleIdList": ["10.3390/molecules26092540", "PMC8123587", "33925346"]}, {"Citation": "Oz A.T., Kafkas E. Phytochemicals in fruits and vegetables. In: Waisundara V., editor. Superfood and Functional Food. IntechOpen; London, UK: 2017. pp. 175\u2013184."}, {"Citation": "Bertelli A., Biagi M., Corsini M., Baini G., Cappellucci G., Miraldi E. Polyphenols: From theory to practice. Foods. 2021;10:2595. doi: 10.3390/foods10112595.", "ArticleIdList": ["10.3390/foods10112595", "PMC8621732", "34828876"]}, {"Citation": "Rudrapal M., Khairnar S.J., Khan J., Dukhyil A.B., Ansari M.A., Alomary M.N., Alshabrmi F.M., Palai S., Deb P.K., Devi R. Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action. Front. Pharmacol. 2022;13:283. doi: 10.3389/fphar.2022.806470.", "ArticleIdList": ["10.3389/fphar.2022.806470", "PMC8882865", "35237163"]}, {"Citation": "A\u011fag\u00fcnd\u00fcz D., \u015eahin T.\u00d6., Y\u0131lmaz B., Ekenci K.D., Duyar \u00d6zer \u015e., Capasso R. Cruciferous vegetables and their bioactive metabolites: From prevention to novel therapies of colorectal cancer. Evid.-Based Complement. Altern. Med. 2022;2022:1534083. doi: 10.1155/2022/1534083.", "ArticleIdList": ["10.1155/2022/1534083", "PMC9017484", "35449807"]}, {"Citation": "Koche D., Shirsat R., Kawale M.V. An overerview of major classes of phytochemicals: Their types and role in disease prevention. Hislopia J. 2016;9:1\u201311."}, {"Citation": "Mani V., Park S., Kim J.A., Lee S.I., Lee K. Metabolic perturbation and synthetic biology strategies for plant terpenoid production\u2014An updated overview. Plants. 2021;10:2179. doi: 10.3390/plants10102179.", "ArticleIdList": ["10.3390/plants10102179", "PMC8539415", "34685985"]}, {"Citation": "Hussain M., Debnath B., Qasim M., Bamisile B.S., Islam W., Hameed M.S., Wang L., Qiu D. Role of saponins in plant defense against specialist herbivores. Molecules. 2019;24:2067. doi: 10.3390/molecules24112067.", "ArticleIdList": ["10.3390/molecules24112067", "PMC6600540", "31151268"]}, {"Citation": "Zhang Y.J., Gan R.Y., Li S., Zhou Y., Li A.N., Xu D.P., Li H.B. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015;20:21138\u201321156. doi: 10.3390/molecules201219753.", "ArticleIdList": ["10.3390/molecules201219753", "PMC6331972", "26633317"]}, {"Citation": "Kibe M.N., Konyole S., Nguka G., Oloo M.O., Kathure D., Wangari P.M. The role of phytochemicals in prevention and control of chronic diseases. Int. J. Curr. Res. 2017;9:62540\u201362543."}, {"Citation": "Hosseini S.A., Zand H., Cheraghpour M. The influence of curcumin on the downregulation of MYC, insulin and IGF-1 receptors: A possible mechanism underlying the anti-growth and anti-migration in chemoresistant colorectal cancer cells. Medicina. 2019;55:90. doi: 10.3390/medicina55040090.", "ArticleIdList": ["10.3390/medicina55040090", "PMC6524349", "30987250"]}, {"Citation": "Banik U., Parasuraman S., Adhikary A.K., Othman N.H. Curcumin: The spicy modulator of breast carcinogenesis. J. Exp. Clin. Cancer Res. 2017;36:98. doi: 10.1186/s13046-017-0566-5.", "ArticleIdList": ["10.1186/s13046-017-0566-5", "PMC5517797", "28724427"]}, {"Citation": "Lin X., Bai D., Wei Z., Zhang Y., Huang Y., Deng H., Huang X. Curcumin attenuates oxidative stress in RAW264. 7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS ONE. 2019;14:e0216711.", "ArticleIdList": ["PMC6528975", "31112588"]}, {"Citation": "Shin S.A., Joo B.J., Lee J.S., Ryu G., Han M., Kim W.Y., Park H.H., Lee J.H., Lee C.S. Phytochemicals as anti-inflammatory agents in animal models of prevalent inflammatory diseases. Molecules. 2020;25:5932. doi: 10.3390/molecules25245932.", "ArticleIdList": ["10.3390/molecules25245932", "PMC7765227", "33333788"]}, {"Citation": "Yang M., Kan L., Wu L., Zhu Y., Wang Q. Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism. Exp. Ther. Med. 2019;17:2071\u20132076. doi: 10.3892/etm.2019.7181.", "ArticleIdList": ["10.3892/etm.2019.7181", "PMC6396004", "30867693"]}, {"Citation": "Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J. Ethanopharmacol. 2002;81:81\u2013100. doi: 10.1016/S0378-8741(02)00059-4.", "ArticleIdList": ["10.1016/S0378-8741(02)00059-4", "12020931"]}, {"Citation": "Prabhakar P.K., Doble M. Mechanism of Action of Natural Products Used in the Treatment of Diabetes Mellitus. Chin. J. Int. Med. 2011;17:563\u2013574. doi: 10.1007/s11655-011-0810-3.", "ArticleIdList": ["10.1007/s11655-011-0810-3", "21826590"]}, {"Citation": "Hussein G.M., Matsuda H., Nakamura S., Hamao M., Akiyama T., Tamura K., Yoshikawa M. Mate tea (Ilex paraguariensis) promotes satiety and body weight lowering in mice: Involvement of glucagon-like peptide-1. Biol. Pharm. Bull. 2011;34:1849\u20131855. doi: 10.1248/bpb.34.1849.", "ArticleIdList": ["10.1248/bpb.34.1849", "22130241"]}, {"Citation": "Akawa A.B., Oyinloye B.E., Ajiboye B.O. Computer-aided Identification of Bioactive Compounds from Brachystegia eurycoma with Therapeutic Potential against Drug Targets of Type 2 Diabetes mellitus. Biointerface Res. Appl. Chem. 2022;13:454"}, {"Citation": "Ajiboye B.O., Iwaloye O., Owolabi O.V., Ejeje J.N., Okerewa A., Johnson O.O., Udebor A.E., Oyinloye B.E. Screening of potential antidiabetic phytochemicals from Gongronema latifolium leaf against therapeutic targets of type 2 diabetes mellitus: Multi-targets drug design. SN Appl. Sci. 2022;4:14. doi: 10.1007/s42452-021-04880-2.", "ArticleIdList": ["10.1007/s42452-021-04880-2"]}, {"Citation": "Liu J., Yin F., Xiao H., Guo L., Gao X. Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced \u03b2-cell apoptosis. Toxicol. Vitr. 2012;26:1093\u20131097. doi: 10.1016/j.tiv.2012.07.004.", "ArticleIdList": ["10.1016/j.tiv.2012.07.004", "22819839"]}, {"Citation": "Hlebowicz J., Hlebowicz A., Lindstedt S., Bj\u00f6rgell O., H\u00f6glund P., Holst J.J., Darwiche G., Almer L.O. Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. Am. J. Clin. Nutr. 2009;89:815\u2013821. doi: 10.3945/ajcn.2008.26807.", "ArticleIdList": ["10.3945/ajcn.2008.26807", "19158209"]}, {"Citation": "Ribnicky D.M., Poulev A., Watford M., Cefalu W.T., Raskin I. Antihyperglycemic activity of Tarralin\u2122, an ethanolic extract of Artemisia dracunculus L. Phytomedicine. 2006;3:550\u2013557. doi: 10.1016/j.phymed.2005.09.007.", "ArticleIdList": ["10.1016/j.phymed.2005.09.007", "16920509"]}, {"Citation": "Park S., Ahn I.S., Kim J.H., Lee M.R., Kim J.S., Kim H.J. Glyceollins, one of the phytoalexins derived from soybeans under fungal stress, enhance insulin sensitivity and exert insulinotropic actions. J. Agric. Food Chem. 2010;58:1551\u20131557. doi: 10.1021/jf903432b.", "ArticleIdList": ["10.1021/jf903432b", "20067288"]}, {"Citation": "Ur\u00edas-Silvas J.E., Cani P.D., Delm\u00e9e E., Neyrinck A., L\u00f3pez M.G., Delzenne N.M. Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br. J. Nutr. 2008;99:254\u2013261. doi: 10.1017/S0007114507795338.", "ArticleIdList": ["10.1017/S0007114507795338", "17711612"]}, {"Citation": "Habib N.C., Honor\u00e9 S.M., Genta S.B., S\u00e1nchez S.S. Hypolipidemic effect of Smallanthus sonchifolius (yacon) roots on diabetic rats. Chem. Biol. Interact. 2011;194:31\u201339. doi: 10.1016/j.cbi.2011.08.009.", "ArticleIdList": ["10.1016/j.cbi.2011.08.009", "21907189"]}, {"Citation": "Suleman K.Y. Ph.D. Dissertation. Nelson Mandela Metropolitan University; Port Elizabeth, South Africa: 2009. The Effects of a Kenyan Antidiabetic Plant on Insulin Homeostasis. Chapter IV: Insulin release."}, {"Citation": "Huang T., Lu K.N., Pai Y.P., Hsu C., Huang C.J. Role of GLP1 in the Hypoglycemic Effects of Wild Bitter Gourd. Evid.-Based Complement. Altern. Med. 2013;2013:625892. doi: 10.1155/2013/625892.", "ArticleIdList": ["10.1155/2013/625892", "PMC3621175", "23589719"]}, {"Citation": "Freeland K.R., Wilson C., Wolever T.M. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br. J. Nutr. 2010;103:82\u201390. doi: 10.1017/S0007114509991462.", "ArticleIdList": ["10.1017/S0007114509991462", "19664300"]}, {"Citation": "Yogisha S., Raveesha K.A. Dipeptidyl Peptidase IV inhibitory activity of Mangifera indica. J. Nat. Prod. 2010;3:76\u201379."}, {"Citation": "Pasman W.J., Heimerikx J., Rubingh C.M., van den Berg R., O\u2019Shea M., Gambelli L., Hendriks H.F.J., Einerhand A.W.C., Scott C., Keizer H.G., et al. The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women. Lipids Health Dis. 2008;20:10. doi: 10.1186/1476-511X-7-10.", "ArticleIdList": ["10.1186/1476-511X-7-10", "PMC2322999", "18355411"]}, {"Citation": "Cicero A.F., Tartagni E. Antidiabetic properties of berberine: From cellular pharmacology to clinical effects. Hosp. Pract. 2012;40:56\u201363. doi: 10.3810/hp.2012.04.970.", "ArticleIdList": ["10.3810/hp.2012.04.970", "22615079"]}, {"Citation": "Zhang Y., Cai J., Ruan H., Pi H., Wu J. Antihyperglycemic Activity of Kinsenoside, a High Yielding Constituent from Anoectochilus roxburghii in Streptozotocin Diabetic Rats. J. Ethnopharmacol. 2007;114:141\u2013145. doi: 10.1016/j.jep.2007.05.022.", "ArticleIdList": ["10.1016/j.jep.2007.05.022", "17869039"]}, {"Citation": "Ghosh T., Maity T.K., Singh J. Antihyperglycemic activity of bacosine, a triterpene from Bacopa monnieri, in alloxan-induced diabetic rats. Planta Medica. 2011;77:804\u2013808. doi: 10.1055/s-0030-1250600.", "ArticleIdList": ["10.1055/s-0030-1250600", "21154199"]}, {"Citation": "Potdar D., Hirwani R.R., Dhulap S. Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia. 2012;83:817\u2013830. doi: 10.1016/j.fitote.2012.04.012.", "ArticleIdList": ["10.1016/j.fitote.2012.04.012", "22808523"]}, {"Citation": "Ruhil S., Balhara M., Dhankhar S., Chhillar A.K. Aegle marmelos (Linn.) Correa: A potential source of Phytomedicine. J. Med. Plant Res. 2011;5:1497\u20131507."}, {"Citation": "Samad M.B., Mohsin M.N.A.B., Razu B.A., Hossain M.T., Mahzabeen S., Unnoor N., Muna I.A., Akhter F., Kabir A.U., Hannan J.M.A. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic \u03b2-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb/db type 2 diabetic mice. BMC Complement. Altern. Med. 2017;17:395.", "ArticleIdList": ["PMC5550996", "28793909"]}, {"Citation": "Naik S.R., Barbosa Filho J.M., Dhuley J.N., Deshmukh V. Probable Mechanism of Hypoglycemic Activity of Bassic Acid, a Natural Product Isolated from Bumelia sartorum. J. Ethnopharmacol. 1991;33:37\u201344. doi: 10.1016/0378-8741(91)90158-A.", "ArticleIdList": ["10.1016/0378-8741(91)90158-A", "1943171"]}, {"Citation": "Benhaddou-Andaloussi A., Martineau L.C., Spoor D., Vuong T., Leduc C., Joly E., Burt A., Meddah B., Settaf A., Arnason J.T., et al. Antidiabetic activity of Nigella sativa. Seed extract in cultured pancreatic \u03b2-cells, skeletal muscle cells, and adipocytes. Pharm. Biol. 2008;46:96\u2013104. doi: 10.1080/13880200701734810.", "ArticleIdList": ["10.1080/13880200701734810"]}, {"Citation": "Takikawa M., Kurimoto Y., Tsuda T. Curcumin stimulates glucagon-like peptide- 1 secretion in GLUTag cells via Ca2+/calmodulin-dependent kinase II activation. Biochem. Biophys. Res. Commun. 2013;435:165\u2013170. doi: 10.1016/j.bbrc.2013.04.092.", "ArticleIdList": ["10.1016/j.bbrc.2013.04.092", "23660191"]}, {"Citation": "Tsoukalas M., Muller C.D., Lobstein A., Urbain A. Pregnane glycosides from Cynanchum marnierianum stimulate GLP-1 secretion in STC-1 cells. Planta Medica. 2016;82:992\u2013999. doi: 10.1055/s-0042-107675.", "ArticleIdList": ["10.1055/s-0042-107675", "27224272"]}, {"Citation": "Kartinah N.T., Fadilah F., Ibrahim E.I., Suryati Y. The potential of Hibiscus sabdariffa Linn in inducing glucagon-like peptide-1 via SGLT-1 and GLPR in DM Rats. BioMed Res. Int. 2019;2019:8724824. doi: 10.1155/2019/8724824.", "ArticleIdList": ["10.1155/2019/8724824", "PMC6885171", "31828140"]}, {"Citation": "Dans A.M.L., Villarruz M.V.C., Jimeno C.A., Javelosa M.A.U., Chua J., Bautista R., Velez G.G.B. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J. Clin. Epidemiol. 2007;60:554\u2013559. doi: 10.1016/j.jclinepi.2006.07.009.", "ArticleIdList": ["10.1016/j.jclinepi.2006.07.009", "17493509"]}, {"Citation": "Wang Y., Wang A., AlKhalidy H., Luo J., Moomaw E., Neilson A.P., Liu D. Flavone Hispidulin Stimulates Glucagon-Like Peptide-1 Secretion and Ameliorates Hyperglycemia in Streptozotocin-Induced Diabetic Mice. Mol. Nutr. Food Res. 2020;64:e1900978. doi: 10.1002/mnfr.201900978.", "ArticleIdList": ["10.1002/mnfr.201900978", "PMC7473469", "31967385"]}, {"Citation": "Zhang W., Zhang F., Hu Q., Xiao X., Ou L., Chen Y., Luo S., Cheng Y., Jiang Y., Ma X., et al. The emerging possibility of the use of geniposide in the treatment of cerebral diseases: A review. Chin. Med. 2021;16:86. doi: 10.1186/s13020-021-00486-3.", "ArticleIdList": ["10.1186/s13020-021-00486-3", "PMC8400848", "34454545"]}, {"Citation": "Kato M., Tani T., Terahara N., Tsuda T. The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway. PLoS ONE. 2015;10:e0126157. doi: 10.1371/journal.pone.0126157.", "ArticleIdList": ["10.1371/journal.pone.0126157", "PMC4427495", "25962102"]}, {"Citation": "Kim K.-S., Yang H.J., Lee I.-S., Kim K.-H., Park J., Jeong H.-S., Kim Y., Ahn K.S., Na Y.-C., Jang H.-J. The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice. Sci. Rep. 2015;5:18325. doi: 10.1038/srep18325.", "ArticleIdList": ["10.1038/srep18325", "PMC4682129", "26675132"]}, {"Citation": "Zhang L., Zhang S.-T., Yin Y.-C., Xing S., Li W.-N., Fu X.-Q. Hypoglycemic effect and mechanism of isoquercitrin as an inhibitor of dipeptidyl peptidase-4 in type 2 diabetic mice. RSC Adv. 2018;8:14967\u201314974. doi: 10.1039/C8RA00675J.", "ArticleIdList": ["10.1039/C8RA00675J", "PMC9080018", "35541310"]}, {"Citation": "Song W.-Y., Aihara Y., Hashimoto T., Kanazawa K., Mizuno M. (\u2212)-Epigallocatechin-3-gallate induces secretion of anorexigenic gut hormones. J. Clin. Biochem. Nutr. 2015;57:164\u2013169. doi: 10.3164/jcbn.15-50.", "ArticleIdList": ["10.3164/jcbn.15-50", "PMC4566026", "26388676"]}, {"Citation": "Kato M., Nishikawa S., Ikehata A., Dochi K., Tani T., Takahashi T., Imaizumi A., Tsuda T. Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Mol. Nutr. Food Res. 2017;61:1600471. doi: 10.1002/mnfr.201600471.", "ArticleIdList": ["10.1002/mnfr.201600471", "27990751"]}, {"Citation": "Kalivarathan J., Kalaivanan K., Chandrasekaran S.P., Nanda D., Ramachandran V., Venkatraman A.C. Apigenin modulates hippocampal CREB-BDNF signaling in high fat, high fructose diet-fed rats. J. Funct. Foods. 2020;68:103898. doi: 10.1016/j.jff.2020.103898.", "ArticleIdList": ["10.1016/j.jff.2020.103898"]}, {"Citation": "Dao T.M., Waget A., Klopp P., Serino M., Vachoux C., Pechere L., Drucker D.J., Champion S., Barth\u00e9lemy S., Barra Y., et al. Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control. PLoS ONE. 2011;6:e20700. doi: 10.1371/journal.pone.0020700.", "ArticleIdList": ["10.1371/journal.pone.0020700", "PMC3108962", "21673955"]}, {"Citation": "Casanova-Mart\u00ed \u00c0., Serrano J., Blay M.T., Terra X., Ard\u00e9vol A., Pinent M. Acute selective bioactivity of grape seed proanthocyanidins on enteroendocrine secretions in the gastrointestinal tract. Food Nutr. Res. 2017;61:1321347. doi: 10.1080/16546628.2017.1321347.", "ArticleIdList": ["10.1080/16546628.2017.1321347", "PMC5475339", "28659730"]}, {"Citation": "Rehman K., Ali M.B., Akash M.S.H. Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses. Biomed. Pharmacother. 2019;112:108670. doi: 10.1016/j.biopha.2019.108670.", "ArticleIdList": ["10.1016/j.biopha.2019.108670", "30784939"]}, {"Citation": "Gonz\u00e1lez-Abu\u00edn N., Mart\u00ednez-Micaelo N., Blay M., Ard\u00e9vol A., Pinent M. Grape-Seed Procyanidins Prevent the Cafeteria-DietInduced Decrease of Glucagon-Like Peptide-1 Production. J. Agric. Food Chem. 2014;62:1066\u20131072. doi: 10.1021/jf405239p.", "ArticleIdList": ["10.1021/jf405239p", "24410268"]}, {"Citation": "Lalitha N., Sadashivaiah B., Ramaprasad T.R., Singh S.A. Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein. PLoS ONE. 2020;15:e0231543. doi: 10.1371/journal.pone.0231543.", "ArticleIdList": ["10.1371/journal.pone.0231543", "PMC7153899", "32282828"]}, {"Citation": "Kwon E.-Y., Choi M.-S. Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. Nutrients. 2018;10:1415. doi: 10.3390/nu10101415.", "ArticleIdList": ["10.3390/nu10101415", "PMC6213163", "30282902"]}, {"Citation": "Araj-Khodaei M., Ayati M.H., Zeinalhajlou A.A., Novinbahador T., Yousefi M., Shiri M., Mahmoodpoor A., Shamekh A., Namazi N., Sanaie S. Berberine-induced glucagon-like peptide-1 and its mechanism for controlling types 2 diabetes mellitus: A comprehensive pathway review. Arch. Physiol. Biochem. 2023;3:1\u20138.", "ArticleIdList": ["37921026"]}, {"Citation": "Yusta B., Baggio L.L., Estall J.L., Koehler J.A., Holland D.P., Li H., Pipeleers D., Ling Z., Drucker D.J. GLP-1 Receptor Activation Improves Beta Cell Function and Survival Following Induction of Endoplasmic Reticulum Stress. Cell Metab. 2006;4:391\u2013406. doi: 10.1016/j.cmet.2006.10.001.", "ArticleIdList": ["10.1016/j.cmet.2006.10.001", "17084712"]}, {"Citation": "Oh Y.S., Jun H.-S. Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling. Int. J. Mol. Sci. 2017;19:26. doi: 10.3390/ijms19010026.", "ArticleIdList": ["10.3390/ijms19010026", "PMC5795977", "29271910"]}, {"Citation": "Zummo F.P., Cullen K.S., Honkanen-Scott M., Shaw J.A.M., Lovat P.E., Arden C. Glucagon-Like Peptide 1 Protects Pancreatic \u03b2-Cells from Death by Increasing Autophagic Flux and Restoring Lysosomal Function. Diabetes. 2017;66:1272\u20131285. doi: 10.2337/db16-1009.", "ArticleIdList": ["10.2337/db16-1009", "28232493"]}, {"Citation": "Ezanno H., Pawlowski V., Abdelli S., Boutry R., Gmyr V., Kerr-Conte J., Bonny C., Pattou F., Abderrahmani A. JNK3 Is Required for the Cytoprotective Effect of Exendin 4. J. Diabetes Res. 2014;2014:814854. doi: 10.1155/2014/814854.", "ArticleIdList": ["10.1155/2014/814854", "PMC4083605", "25025079"]}, {"Citation": "Camaya I., Donnelly S., O\u2019Brien B. Targeting the PI3K/Akt Signaling Pathway in Pancreatic \u0392-cells to Enhance Their Survival and Function: An Emerging Therapeutic Strategy for Type 1 Diabetes. J. Diabetes. 2022;14:247\u2013260. doi: 10.1111/1753-0407.13252.", "ArticleIdList": ["10.1111/1753-0407.13252", "PMC9060113", "35191175"]}, {"Citation": "Quoyer J., Longuet C., Broca C., Linck N., Costes S., Varin E., Bockaert J., Bertrand G., Dalle S. GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a Beta-Arrestin 1-Mediated ERK1/2 Activation in Pancreatic Beta-Cells. J. Biol. Chem. 2010;285:1989\u20132002. doi: 10.1074/jbc.M109.067207.", "ArticleIdList": ["10.1074/jbc.M109.067207", "PMC2804357", "19915011"]}, {"Citation": "Lee W.-Y. New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic \u03b2-Cells and Hepatocytes. Endocrinol. Metab. 2017;32:1\u20135. doi: 10.3803/EnM.2017.32.1.1.", "ArticleIdList": ["10.3803/EnM.2017.32.1.1", "PMC5368107", "28181428"]}, {"Citation": "Tong X., Kono T., Anderson-Baucum E.K., Yamamoto W., Gilon P., Lebeche D., Day R.N., Shull G.E., Evans-Molina C. SERCA2 Deficiency Impairs Pancreatic \u03b2-Cell Function in Response to Diet-Induced Obesity. Diabetes. 2016;65:3039\u20133052. doi: 10.2337/db16-0084.", "ArticleIdList": ["10.2337/db16-0084", "PMC5033263", "27489309"]}, {"Citation": "Jhala U.S., Canettieri G., Screaton R.A., Kulkarni R.N., Krajewski S., Reed J., Walker J., Lin X., White M., Montminy M. CAMP Promotes Pancreatic Beta-Cell Survival via CREB-Mediated Induction of IRS2. Genes. Dev. 2003;17:1575\u20131580. doi: 10.1101/gad.1097103.", "ArticleIdList": ["10.1101/gad.1097103", "PMC196130", "12842910"]}, {"Citation": "Tenenbaum M., Plaisance V., Boutry R., Pawlowski V., Jacovetti C., Sanchez-Parra C., Ezanno H., Bourry J., Beeler N., Pasquetti G., et al. The Map3k12 (Dlk)/JNK3 Signaling Pathway Is Required for Pancreatic Beta-Cell Proliferation during Postnatal Development. Cell. Mol. Life Sci. 2021;78:287\u2013298. doi: 10.1007/s00018-020-03499-7.", "ArticleIdList": ["10.1007/s00018-020-03499-7", "PMC11072213", "32189007"]}, {"Citation": "Malgaonkar M., Shirolkar A., Murthy S.N., Pawar S. Medicinal Plants-Recent. Advances in Research and Development. Springer; Singapore: 2016. Ayurvedic Plants with Antidiabetic Potential; pp. 439\u2013468."}, {"Citation": "Tzeng T.F., Liou S.S., Liu I.M. The selected traditional chinese medicinal formulas for treating diabetic nephropathy: Perspective of modern science. J. Tradit. Complement. Med. 2013;3:152\u2013158. doi: 10.4103/2225-4110.114893.", "ArticleIdList": ["10.4103/2225-4110.114893", "PMC3897216", "24716171"]}, {"Citation": "Xu M., Wu H.Y., Liu H., Gong N., Wang Y.R., Wang Y.X. Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors. Br. J. Pharmacol. 2017;174:580\u2013590. doi: 10.1111/bph.13720.", "ArticleIdList": ["10.1111/bph.13720", "PMC5345663", "28098360"]}, {"Citation": "Park C.H., Noh J.S., Kim J.H., Tanaka T., Zhao Q., Matsumoto K., Shibahara N., Yokozawa T. Evaluation of morroniside, iridoid glycoside from Corni Fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice. Biol. Pharm. Bull. 2011;34:1559\u20131565. doi: 10.1248/bpb.34.1559.", "ArticleIdList": ["10.1248/bpb.34.1559", "21963495"]}, {"Citation": "Tang H.C., Chen C.Y.C. Design of Glucagon-like peptide-1 receptor agonist for diabetes mellitus from traditional Chinese medicine. Evid.-Based Complement. Altern. Med. 2014;2014:385120. doi: 10.1155/2014/385120.", "ArticleIdList": ["10.1155/2014/385120", "PMC4033432", "24891870"]}, {"Citation": "Hu D., Gao J., Yang X., Liang Y. A Comprehensive Mini-Review of Curcumae Radix: Ethnopharmacology, Phytochemistry, and Pharmacology. Nat. Prod. Commun. 2021;16:1934578X211020628. doi: 10.1177/1934578X211020628.", "ArticleIdList": ["10.1177/1934578X211020628"]}, {"Citation": "Han L.K., Zheng Y.N., Yoshikawa M., Okuda H., Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement. Altern. Med. 2005;5:9. doi: 10.1186/1472-6882-5-9.", "ArticleIdList": ["10.1186/1472-6882-5-9", "PMC1097713", "15811191"]}, {"Citation": "Mohammed A., Tajuddeen N. Antidiabetic compounds from medicinal plants traditionally used for the treatment of diabetes in Africa: A review update (2015\u20132020) S. Afr. J. Bot. 2022;146:585\u2013602. doi: 10.1016/j.sajb.2021.11.018.", "ArticleIdList": ["10.1016/j.sajb.2021.11.018"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "7"}, {"Year": "2024", "Month": "5", "Day": "28"}, {"Year": "2024", "Month": "6", "Day": "3"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "1", "Minute": "23"}, {"Year": "2024", "Month": "6", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["38931402", "PMC11206448", "10.3390/ph17060736", "ph17060736"]}}]}